eccogene glp-1 Enters Exclusive License Agreement With AstraZeneca to Develop and Commercialize Small Molecule Receptor Agonist ECC5004 for Cardiometabolic Diseases Oral GLP-1 Market to Rise
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12































